Company intelligence / Profile preview

Bluedrop Medical

Ownership: Private
Development stage: Commercial

Overview

Bluedrop Medical has developed a patented home-use device that enables daily thermal and visual scans of the feet to detect early signs of diabetic foot ulcers. Data are analyzed remotely using AI algorithms to identify risk areas and alert clinicians or patients as needed. The system aims to reduce unnecessary amputations by enabling earlier intervention. Clinical results are not detailed in public sources but the solution is described as "game changing" for an unmet need in diabetes care.

Therapeutic areas: Endocrinology
Modalities: DeviceDigital health platformArtificial intelligence (AI)Machine learningInternet of Things (IoT)
Industry: Physiological Monitoring

Partnerships

Not specified; investors include several VC funds but no major pharma/biotech partnerships disclosed.

Beyond the preview

Go deeper on Bluedrop Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bluedrop Medical.

Explore the full profile